The device failures could lead to increased or decreased values of CO2, which could be fatal, according to a U.S. Food and Drug Administration news release. Additionally, physicians may make clinical decisions based off incorrect displayed values, potentially causing permanent impairment or life-threatening changes.
Currently there have been no reports of injury or death associated with the recalled device, according to the news release.
More articles on recalls:
American Health Packaging recalls oxcarbazepine, ibuprofren for mislabeled packages
Baxter initiates worldwide saline solution recall
Hospira recalls Encore Infusion pumps
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
